Phasebio: See Their Revenue, Competitors, Traffic, and Reviews (August 2025)

Review (August 2025)

1.32M

Estimated Revenue

10k

Website Visitors

4/5

Trustpilot Score

What do we know about PhaseBio Pharmaceuticals, Inc.?

Estimated Revenue (2020)

$1.32M

Total Employees

51 Founded

2002

Industry

Biotechnology

Location

Malvern, United States

About

PhaseBio Pharmaceuticals, Inc.:

Social Links

What is PhaseBio Pharmaceuticals, Inc.'s Revenue?

PhaseBio Pharmaceuticals, Inc.'s estimated revenue for 2024 is $1.32M.

What does PhaseBio Pharmaceuticals, Inc. do?

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases. The company's pipeline includes: bentracimab (PB2452), a novel reversal agent for the antiplatelet therapy ticagrelor; pemziviptadil (PB1046), a once-weekly vasoactive intestinal peptide receptor agonist for the treatment of pulmonary arterial hypertension; and PB6440, an oral agent for the treatment of resistant hypertension. PhaseBio's proprietary elastin-like polypeptide technology platform enables the development of therapies with potential for less-frequent dosing and improved pharmacokinetics, including pemziviptadil, and drives both internal and partnership drug-development opportunities. Looking for a new role? Please visit our careers page to find out more about our open jobs and benefits at https://phasebio.com/careers/

Samys

Shop samy's camera online or in california for photography equipment including new and used digital and film cameras and lenses, video cameras, tripods, lighting and studio gear, underwater photography equipment and more from top selling brands, canon, nikon, sony, gopro, panasonic, olympus, fuji, leica and more.... More